Maxim Group Upgrades Reviva Pharmaceuticals (RVPH) to Buy
Tweet Send to a Friend
(Updated - January 10, 2025 10:39 AM EST)
Maxim Group analyst Jason McCarthy upgraded Reviva Pharmaceuticals (NASDAQ: RVPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Maxim Group analyst Jason McCarthy upgraded Reviva Pharmaceuticals (NASDAQ: RVPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
